PegBio Schedules 25 August 2026 Board Meeting to Approve 1H26 Interim Results
Bulletin Express
Aug 13
PegBio Co., Ltd. announced that its board of directors will convene on 25 August 2026 to review and approve the Group’s interim financial results for the six months ended 30 June 2026.
The meeting agenda will include consideration of the interim accounts, authorization of their publication, and other corporate matters.
The announcement was signed by Dr. Michael Min Xu, Chairman, Executive Director and General Manager, and was dated 13 August 2026 in Hong Kong.
As disclosed, the Board currently consists of nine directors: two executive directors, four non-executive directors, and three independent non-executive directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.